Mesa Laboratories Inc /Co/ (MLAB)
A forensic read on Mesa Laboratories Inc /Co/ built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.
Mesa Laboratories designs and manufactures quality control solutions for regulated applications in the pharmaceutical, healthcare, and medical device industries, operating through four segments: Sterilization and Disinfection Control, Biopharmaceutical Development, Calibration Solutions, and Clinical Genomics. The company's financial trajectory shows a return to profitability, with revenue growing from $241.0 million in FY2025 to $249.1 million in FY2026, while net margin expanded from -0.8% to 2.7%.
The forensic grade and screens above are free — no account needed. Want the AI investment read on top — the 0–100 rating, thesis, bull-vs-bear, red flags and the 12-month scenario, written from Mesa Laboratories Inc /Co/'s actual 10-K/10-Q/8-K filings?
Generate the AI investment read →No credit card · informational only, not investment advice · see the track record
← Browse all forensic stock analyses
Data from SEC EDGAR public filings · metrics as of Aug 5, 2026. Forensic signals flag probability, not certainty.